Dr. Knudsen will share her experience with the rapidly growing and groundbreaking use of clinical genomics in oncology, including what gaps still need to be addressed. She will also share her thoughts on the critical role of the public and private sector in advocating for the use of clinical genomics in oncology.

"Dr. Knudsen and the American Cancer Society are incredible advocates for cancer patients and their loved ones," said Dr. Phil Febbo. "As genomics continues to revolutionize how we detect, diagnose, and treat cancer, it will be fabulous to talk to Dr. Knudsen about how cancer genomics can best improve patient outcomes."